Better than expected revenues and profits on the horizon at detection tech group

Detection technology company, Kromek, says it looks forward to delivering revenue and profits ahead of market forecasts in its full year 2025 trading update today.

It expects to report FY 2025 revenue of not less than £26m, representing year-on-year growth of at least 34 per cent. Profit before tax is also expected to be slightly ahead of market expectations.

Looking beyond FY 2025, Huddersfield-based Kromek anticipates delivering revenue growth for the fifth consecutive year in FY 2026, while also maintaining profitability.

It explains that this positive outlook is underpinned by contracted revenue of about £20m and a “substantial” near-term revenue pipeline.

Arnab Basu, chief executive officer, said: “FY 2025 has been a transformative year for Kromek. Our landmark agreement with Siemens Healthineers not only validates our leadership in Advanced Imaging technology but has also significantly strengthened our financial position – enabling us to substantially reduce debt and report pre-tax profitability for the first time.

“While the CBRN (chemical, biological, radiological and nuclear) detection segment experienced a slower start, momentum returned in the second half, supported by UK government frameworks, US federal contracts, and a healthy international sales pipeline.

“This gives us confidence in sustainable growth for the year ahead.

“Looking forward, with contracted revenues of approximately £20m, we have strong visibility for FY 2026 and are well-positioned to deliver another year of revenue growth, at least in line with market expectations, driving long-term value for our shareholders.”